[Pharmacological properties of some 5-oxytryptamine salts].
D000272:Adipates / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002199:Capillary Permeability; D002415:Cats; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D003404:Creatinine / Q000008:administration & dosage* / Q000633:toxicity; D003864:Depression, Chemical; D004285:Dogs; D004355:Drug Stability; D004423:Ear / Q000098:blood supply; D005260:Female; D006863:Hydrogen-Ion Concentration; D007668:Kidney / Q000187:drug effects; D008298:Maleates / Q000494:pharmacology*; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D012039:Regional Blood Flow / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D012701:Serotonin / Q000008:administration & dosage* / Q000633:toxicity; D012995:Solubility; D013154:Spleen / Q000187:drug effects; D013268:Stimulation, Chemical; D013386:Succinates / Q000008:administration & dosage* / Q000494:pharmacology* / Q000633:toxicity; D013431:Sulfates / Q000633:toxicity; D014599:Uterus / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology
D000272:Adipates; D008298:Maleates; D013386:Succinates; D013431:Sulfates; D014665:Vasodilator Agents; D012701:Serotonin; D003404:Creatinine
Farmakologicheskie svoĭstva nekotorykh soleĭ 5-oksitriptamina.